Essential fatty acid preparation improves biochemical and cognitive functions in experimental allergic encephalomyelitis rats

European Journal of Pharmacology

Volumn 328, Issue 1, 1997, Pages 23-29

  Yehuda, Shlomo ^a   Rabinovitz, Sharon ^a   Mostofsky, David I ^b   Huberman, Moshe ^c   Sredni, Benjamin ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b BOSTON UNIVERSITY   (United States)

^c MEIR MEDICAL CENTER   (Israel)

Author keywords

Experimental allergic encephalomyelitis; Fatty acid; Linolenic acid; Multiple sclerosis; Linolenic acid

Indexed keywords

ESSENTIAL FATTY ACID; LINOLEIC ACID; LINOLENIC ACID; MYELIN; SR 3; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BRAIN SYNAPTOSOME; COGNITION; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING DISORDER; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030951266     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)83022-1     Document Type: Article

References (28)

1. Brandeis R., Brandys Y., Yehuda S. The use of the Morris water maze in the study of memory and learning. Int. J. Neurosci. 48:1984;29-69.
2. Cunnane S.C., Ho S.Y., Dore-Duffy P., Ellis K.R., Horrobin D.F. Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis. Am. J. Clin. Nutr. 50:1989;801-806.
3. Dhopeshwarkar, G.A., 1983. Nutrition and Brain Development. Plenum Press, New York, NY.
4. Field, E.J., 1989. Multiple Sclerosis. C.C. Thomas, Springfield, CA.
5. Folch-Pi J., Lees M., Slonane-Stanley G.M. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:1957;497-509.
6. Geny C., Pradat P.F., Yulis J., Walter S., Cesaro D., Degos J.D. Hypothermia, Wernicke encephalopathy and multiple sclerosis. Acta Neurol. Scand. 86:1992;632-634.
7. Holman R.T., Johnson S.B., Kokmen E. Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proc. Natl. Acad. Sci. USA. 86:1989;4720-4724.
8. Kwon E.E., Prineas J.W. Blood-brain barrier abnormalities in long-standing multiple sclerosis. J. Neuropathol. Exp. Neurol. 53:1994;625-636.
9. Lammens M., Lissoir F., Carton H. Hypothermia in three patients with multiple sclerosis. Clin. Neurol. Neurosurg. 91:1989;117-121.
10. Newcomb J., Li H., Cuzner M.L. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis. Neuropathol. Appl. Neurobiol. 20:1994;152-162.
11. Nicholas H.J., Taylor J. Central nervous system demyelinating diseases and increased release of cholesterol into the urinary system of rats. Lipids. 29:1994;611-617.
12. Nightingale S., Woo E., Smith A.D., French J.M., Gale M.M., Sinclair H.M., Bates D., Shaw D.A. Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis. Acta Neurol. Scand. 82:1990;43-50.
13. Phylactos A.C., Harbige L.S., Crawford M.A. Essential fatty acids alter the activity of manganese-superoxide dismutase in rat heart. Lipids. 29:1994;111-115.
14. Poser C.M. The role of trauma in the pathogenesis of multiple sclerosis: a review. Clin. Neurol. Neurosurg. 96:1994;103-110.
15. Riekkinen M., Riekkinen P. Jr. Effects of THA and physostigmine on spatial navigation and avoidance performance in mecamylamine and PCPA-treated rats. Exp. Neurol. 125:1994;111-118.
16. Riekkinen M., Sirvio J., Riekkinen P. Jr. Pharmacological consequences of nicotinergic plus serotonergic manipulations. Brain Res. 622:1993;139-146.
17. Ron A.M., Feinstein A. Multiple sclerosis and the mind. J. Neurol. Neurosurg. Psychiatry. 55:1992;1-3.
18. Swank R.L., Grimsgaard A. Multiple sclerosis: the lipid relationship. Am. J. Clin. Nutr. 48:1988;1387-1393.
19. Syndyk R., Awerbuch G.I. The relationship between melatonin secretion and serum cholesterol in patients with multiple sclerosis. Int. J. Neurosci. 76:1994;81-86.
20. Wakefield A.J., More L.J., Difford J., McLaughlin J.E. Immunohistochemical study of vascular injury in acute multiple sclerosis. J. Clin. Pathol. 47:1994;129-133.
21. Werkele, H., 1993. Lymphocyte traffic to the brain. In: Pardridge, W.M. (Ed.), The Brain Blood Barrier. Raven Press, New York, NY, pp. 67-83.
22. Whittaker, V.P., Barker, L.A., 1972. The subcellular fractionation of brain tissue with special reference to the preparation of synaptosomes and their component organelles. In: Fried, R. (Ed.), Methods in Neurochemistry. Marcel Dekker, New York, NY, pp. 1-52.
23. Williams K.A., Deber C.M. The structure and function of central nervous system myelin. Crit. Rev. Clin. Lab. Sci. 30:1993;29-64.
24. Yehuda S., Carasso R.L. Modulation of learning, pain thresholds, and thermoregulation in the rat by preparations of free purified-linolenic and linoleic acids: determination of optimal n-3 to n-6 ratio. Proc. Natl. Acad. Sci. USA. 90:1993;10345-10349.
25. Yehuda S., Carasso R.L., Mostofsky D.I. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur. J. Pharmacol. 254:1994;193-198.
26. Yehuda S., Carasso R.L., Mostofsky D.I. Essential fatty acid preparation (SR-3) rehabilitates learning deficits induced by AF64A and 5,7-DHT. NeuroReport. 6:1995;511-515.
27. Yehuda S., Brandys Y., Blumenfeld A. Essential fatty acid preparation reduces cholesterol and fatty acids in rat cortex. Int. J. Neurosci. 86:1996;249-256.
28. Yu G.S.M., Steinkirchner T.M., Rao A.G., Larkin E.C. Effect of prenatal iron deficiency on myelination in rat pups. Am. J. Pathol. 125:1986;620-624.